Life Sciences
AI adoption expands across pharmaceutical workflows
Microsoft reported that AI is increasingly being integrated into pharmaceutical discovery, manufacturing, operations, and commercial workflows.
Microsoft described AI adoption across pharmaceutical and life-sciences workflows, including discovery, development, manufacturing, operations, and commercial activities. The report says organizations are using AI to access evidence more quickly, test more hypotheses, surface institutional knowledge, and support decision-making. It characterizes the sector as moving from experimentation toward integration of AI into core workflows. The source is a Microsoft publication and therefore presents the company’s perspective rather than an independent industry assessment. It does not identify a single newly launched product, customer deployment, or quantified business outcome.
Original source: Microsoft